Treating second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia: Successful salvage rather than
1Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Abstract:
Prognosis of second-relapsed/refractory first-relapsed childhood acute myeloid leukaemia remains poor and there are no clear guidelines on the best treatment approach. The report by White et al. suggests that, while outcomes are still unsatisfactory, there is room to pursue a curative approach rather than palliation. Commentary on: White et al. Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO-DB SHIP consortium. Br J Haematol 2022;197:755-765.
More Related Videos
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Targeted Cancer Therapies
There are several types of targeted therapies against...


